Navidea Biopharmaceuticals, Inc. ( NAVBQ) - Key Metrics
NAVBQ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0 | -$0.02 | -$0.10 | -$0.10 |
| 2023Q2 | $0 | $0.13 | $0.10 | $0.10 |
| 2023Q1 | $0 | -$0.05 | -$0.05 | -$0.05 |
| 2022Q4 | $0 | -$0.11 | -$0.08 | -$0.08 |
| 2022Q3 | $0 | -$0.19 | -$0.06 | -$0.06 |
NAVBQ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -0.99 |
| 2023Q2 | 0% | 0.19 |
| 2023Q1 | 0% | -1.44 |
| 2022Q4 | 0% | -0.48 |
| 2022Q3 | 0% | -0.25 |
NAVBQ
Price: $0
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.20 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 100084